Cochrane Review compares two drugs used for treatment of macular degeneration

Cochrane Review shows how a cheaper alternative to licensed drug for treating eye disease has similar side effects

Neovascular macular degeneration is a progressive and chronic disease of the eye, and a leading cause of blindness in older people globally.

About one in 10 people with macular degeneration suffers legal blindness.


Subscribe to Cochrane RSS